FREE FOR MEMBERS!

Description: In this webinar the pathophysiology of multiple sclerosis (MS)- and how it relates to current and potential biomarkers will be discussed. Neuroimaging is the main biomarker used clinically, but fluid-based biomarker research (blood and CSF) has made tremendous advances. Blood based biomarkers that may be clinically and diagnostically useful are in the horizon and will be explored critically.

Start Date: Upon registration

Completion: Up to 52 weeks

At the end of this webinar you will be able to:

• Know the basics of MS pathology and epidemiology
• Identify current biomarkers in MS
• Become familiarized with emerging fluid biomarkers in MS

Speaker: Carlos Camara-Lemarroy MD

Dr. Carlos Camara completed his internal medicine and neurology residencies at the UANL University Hospital in Monterrey, Mexico. He subsequently completed a two-year MS and Neuroimmunology fellowship at the University of Calgary.

His current research interests include the gut-brain axis, biomarkers and neuroprotection in MS and neuroinflammatory disorders of the CNS. The main focus of this work is translational, where basic neuroscience research is developed into clinical applications and novel therapies for MS and related disorders.

Recorded: November 25, 2021

PEP hours: 1.0

CPS credits: 0

*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.